Click Therapeutics has secured a $20 million term loan from HSBC Innovation Banking. It will use the funds to retire its previous term loan and support the advancement of its prescription digital therapeutic pipeline.
Click Therapeutics develops, validates and commercializes software as prescription medical treatments. The company says it offers accessible, clinically proven, FDA-regulated prescription treatments delivered through a patients’ own digital device.
Click Therapeutics aims to make progress in the treatment of major depressive disorder, schizophrenia, substance use disorders and preventive treatment of migraine. The company’s co-development and commercialization collaborations have positioned it as a player in the Digital Therapeutics™ space.
